ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

286
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
bullishTencent
08 Jul 2019 16:26

HK Connect Ideas: Eight Weeks of Inflows, Sinoma, Sino Biopharm, Meituan/Xiaomi (2019-07-05)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
601 Views
Share
17 Jun 2019 07:16

Hansoh Pharma (翰森制药) Post-IPO Trading Update: Fairly Valued

Hansoh Pharma's IPO was priced at the high end and started trading last Friday. In our earlier note, we argued that the company should trade at...

Logo
656 Views
Share
bullishAlibaba
15 Jun 2019 12:14

ECM Weekly (15 Jun 2019) - Budweiser Brewing Co, Jinxin Fertility, Wanda Sports, Hansoh Pharma

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bullishESR Group
10 Jun 2019 06:45

Last Week in GER Research: ESR Cayman, Hansoh Pharma, China East Education and Tencent

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the valuation for...

Logo
815 Views
Share
bullishESR Group
08 Jun 2019 12:16

ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
x